The Battle of Antibiotics: Linezolid vs. Clindamycin in Necrotizing Fasciitis
Date: Apr 17, 2025 01:00 PM - 02:00 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Jun 17, 2025 01:00 AM
Activity Type
- Application
Target Audience(s)
- Pharmacists
Accreditation(s)
Medical University of South Carolina is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Requirements for CE Credit
In order to receive CE credit, you must register for the program and complete the online evaluation within 60 days of the presentation. CE credit will be posted to CPE Monitor within four weeks following completion of the evaluation.
The Battle of Antibiotics: Linezolid vs. Clindamycin in Necrotizing Fasciitis
Registration Closed
The Battle of Antibiotics: Linezolid vs. Clindamycin in Necrotizing Fasciitis
Registration Closed
Objectives
- Review the pathophysiology of necrotizing skin tissue infections (NSTIs)
- Examine current IDSA guidelines for treating NSTIs
- Evaluate current literature supporting linezolid vs clindamycin for anti-toxin therapy
- Apply the risks and benefits of using linezolid versus clindamycin for a NSTI patient case example
Speaker(s)/Author(s)
|
Samantha Brace, PharmD, MBA
|
Activity Number
0682-0000-25-049-L01-P
Date:
04/17/25
Time:
01:00 PM - 02:00 PM
CE Hours
1.00
Location
Storm Eye Auditorium HA809
Registration Closed